Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAA-specific CTLs in Advanced Breast Cancer
NCT03093350Phase 2Completed
- Sponsor
- Baylor College of Medicine
- Start
- Oct 2017
- Primary completion
- May 2019
- Modality
- Adoptive Cell Transfer
- Countries
- 1
01
Overview
A Phase 2 trial of TAA-CTL in breast cancer, sponsored by Baylor College of Medicine. Started Oct 2017; status: completed.
02
Drugs
TAA-CTL
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT03093350.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03093350.